Sopharma (BGSFA)

Currency in BGN
2.440
-0.010(-0.41%)
Closed·
BGSFA Scorecard
Full Analysis
Valuation implies a strong free cash flow yield
Unusual trading volume
Fair Value
Day's Range
2.4202.440
52 wk Range
2.3007.340
Key Statistics
Bid/Ask
3.94 / 3.99
Prev. Close
5.8
Open
2.44
Day's Range
2.42-2.44
52 wk Range
2.3-7.34
Volume
788.7K
Average Volume (3m)
101.41K
1-Year Change
-58.33%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BGSFA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales decline in the current year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Sopharma Company Profile

Sopharma AD produces, distributes, and exports pharmaceutical products in Europe, Bulgaria, and internationally. It offers Carsil to treat liver disease; Tempalgin, a painkiller; Analgin, a pain reliever; Tabex, a drug used for smoking secession; Tribestan, a drug used for stimulation of the male reproductive system; Broncholytin, which is used to suppress cough; Nivalin for use in the peripheral nervous system; Methylprednisolon for severe allergies and life-threatening conditions; Vitamin C; Valeriana to reduce the stress; and medical devices, such as gauzes, compresses, and dressing. The company also provides food supplements; medicinal and cosmetic products, including plasters, bandages, herbal cosmetics, and sanitary-hygiene products; concentrates for hemodialysis; and prescription medicines, and OTC and veterinary medical products. In addition, the company distributes pharmaceuticals, medical supplies, sanitary materials, vitamins, food supplements, and cosmetics; and provides contract manufacturing services; packaging services; and product development services. Further, it is involved in trading of pharmaceuticals; trades, transports, and packages radioactive materials and nuclear equipment for medicinal use, household electronics, and electrical equipment; purchases, grows, produces, and trades in herbs and medicinal plant; and provision of public opinion research services. Additionally, the company engages in the offline and online retail trade of medicinal products and medical equipment; and franchising, know-how, and rental of properties, as well as in trading, consulting, and other activities. Sopharma AD was founded in 1933 and is headquartered in Sofia, Bulgaria.

Compare BGSFA to Peers and Sector

Metrics to compare
BGSFA
Peers
Sector
Relationship
P/E Ratio
13.8x15.7x−0.5x
PEG Ratio
−0.57−0.010.00
Price/Book
1.4x2.7x2.6x
Price / LTM Sales
0.5x2.1x3.3x
Upside (Analyst Target)
-34.0%43.5%
Fair Value Upside
Unlock12.0%6.3%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.17%
Dividend Yield
4.30%
Industry Median 13.29%
Annualised payout
0.11
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 29, 2025
EPS / Forecast
0.24 / --
Revenue / Forecast
644.00M / --
EPS Revisions
Last 90 days

BGSFA Income Statement

FAQ

What Stock Exchange Does Sopharma AD Trade On?

Sopharma AD is listed and trades on the Sofia Stock Exchange stock exchange.

What Is the Stock Symbol for Sopharma AD?

The stock symbol for Sopharma AD is "BGSFA."

What Is the Sopharma AD Market Cap?

As of today, Sopharma AD market cap is 1.22B.

What Is Sopharma AD's Earnings Per Share (TTM)?

The Sopharma AD EPS (TTM) is 0.17.

When Is the Next Sopharma AD Earnings Date?

Sopharma AD will release its next earnings report on 29 Aug 2025.

From a Technical Analysis Perspective, Is BGSFA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Sopharma AD Stock Split?

Sopharma AD has split 2 times.

How Many Employees Does Sopharma AD Have?

Sopharma AD has 6099 employees.

What is the current trading status of Sopharma AD (BGSFA)?

As of 05 Aug 2025, Sopharma AD (BGSFA) is trading at a price of 2.44, with a previous close of 5.80. The stock has fluctuated within a day range of 2.42 to 2.44, while its 52-week range spans from 2.30 to 7.34.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.